Nasdaq · CIK 0001857044
INDP Indaptus Therapeutics, Inc.
Insider trading from SEC Form 4. Last filing Jul 29, 2025.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
9
with a Form 4 at this company
Signals
Open-market buys and sells at Indaptus Therapeutics, Inc., scored.
No scored open-market trades yet. Grants, exercises and other rows are below.
Transactions
The last 42 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 27, 2025 | Jeffrey A Meckler Chief Executive Officer | AGrant or award Common Stock | +6,068 | $8.30 | $50k | 13,312 | Jul 29, 2025 |
| Jul 27, 2025 | Jeffrey A Meckler Chief Executive Officer | AGrant or award Common Stock Warrantsderivative | +12,136 | $8.30 | $101k | 16,688 | Jul 29, 2025 |
| Jun 10, 2025 | Mark John Gilbert director | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jun 11, 2025 |
| Jun 10, 2025 | William B Hayes director | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jun 11, 2025 |
| Jun 10, 2025 | Hila Karah director | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jun 11, 2025 |
| Jun 10, 2025 | Anthony J Maddaluna director | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jun 11, 2025 |
| Jun 10, 2025 | Robert Martell director | AGrant or award Stock Option (right to buy)derivative | +12,500 | $0.00 | $0 | 12,500 | Jun 11, 2025 |
| Jun 10, 2025 | Roger Pomerantz director | AGrant or award Stock Option (right to buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 11, 2025 |
| Apr 10, 2025 | Anthony J Maddaluna director | DDisposition to issuer Stock Option (right to buy)derivative | -500 | $0.50 | $250 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Nir Sassi Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -1,250 | $0.07 | $89 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Roger Pomerantz director | DDisposition to issuer Stock Option (right to buy)derivative | -500 | $0.50 | $250 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Jeffrey A Meckler Chief Executive Officer | DDisposition to issuer Stock Option (right to buy)derivative | -4,750 | $0.04 | $176 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Walt Addison Linscott Chief Operating Officer | DDisposition to issuer Stock Option (right to buy)derivative | -1,750 | $0.06 | $103 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | William B Hayes director | DDisposition to issuer Stock Option (right to buy)derivative | -500 | $0.50 | $250 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Hila Karah director | DDisposition to issuer Stock Option (right to buy)derivative | -500 | $0.39 | $195 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Anthony J Maddaluna director | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.50 | $125 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | William B Hayes director | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.50 | $125 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Roger Pomerantz director | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.50 | $125 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Jeffrey A Meckler Chief Executive Officer | DDisposition to issuer Stock Option (right to buy)derivative | -3,750 | $0.04 | $139 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Nir Sassi Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -1,125 | $0.07 | $80 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Walt Addison Linscott Chief Operating Officer | DDisposition to issuer Stock Option (right to buy)derivative | -750 | $0.06 | $44 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Hila Karah director | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.39 | $98 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Nir Sassi Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -2,500 | $0.07 | $178 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Anthony J Maddaluna director | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.50 | $125 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | William B Hayes director | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.50 | $125 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Walt Addison Linscott Chief Operating Officer | DDisposition to issuer Stock Option (right to buy)derivative | -1,250 | $0.06 | $74 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Jeffrey A Meckler Chief Executive Officer | DDisposition to issuer Stock Option (right to buy)derivative | -813 | $0.04 | $30 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Roger Pomerantz director | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.50 | $125 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Hila Karah director | DDisposition to issuer Stock Option (right to buy)derivative | -281 | $0.39 | $110 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Nir Sassi Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -500 | $0.07 | $36 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Hila Karah director | DDisposition to issuer Stock Option (right to buy)derivative | -250 | $0.39 | $98 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Jeffrey A Meckler Chief Executive Officer | DDisposition to issuer sStock Option (right to buy)derivative | -1,500 | $0.04 | $56 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Walt Addison Linscott Chief Operating Officer | DDisposition to issuer Stock Option (right to buy)derivative | -1,125 | $0.06 | $66 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Jeffrey A Meckler Chief Executive Officer | DDisposition to issuer Stock Option (right to buy)derivative | -1,563 | $0.04 | $58 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Walt Addison Linscott Chief Operating Officer | DDisposition to issuer Stock Option (right to buy)derivative | -2,500 | $0.06 | $148 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Nir Sassi Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -500 | $0.07 | $36 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Jeffrey A Meckler Chief Executive Officer | DDisposition to issuer Stock Option (right to buy)derivative | -1,250 | $0.04 | $46 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Walt Addison Linscott Chief Operating Officer | DDisposition to issuer Stock Option (right to buy)derivative | -1,125 | $0.06 | $66 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Nir Sassi Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -41 | $0.07 | $3 | 0 | Apr 11, 2025 |
| Apr 10, 2025 | Nir Sassi Chief Financial Officer | DDisposition to issuer Stock Option (right to buy)derivative | -1,125 | $0.07 | $80 | 0 | Apr 11, 2025 |
| Nov 25, 2024 | Jeffrey A Meckler CEO and Director | AGrant or award Common stock | +42,553 | $1.18 | $50k | 202,859 | Nov 26, 2024 |
| Nov 25, 2024 | Jeffrey A Meckler CEO and Director | AGrant or award Common Stock Warrantsderivative | +42,553 | $1.18 | $50k | 42,553 | Nov 26, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Mark John Gilbertdirector
- William B Hayesdirector
- Hila Karahdirector
- Walt Addison LinscottChief Operating Officer
- Anthony J Maddalunadirector
- Robert Martelldirector
- Jeffrey A MecklerChief Executive Officer
- Roger Pomerantzdirector
- Nir SassiChief Financial Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.